This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Secondary Prevention of Osteoporotic Fractures in Residents of Long-Term Care Facilities

This study has been completed.
Information provided by:
Duke University Identifier:
First received: January 20, 2006
Last updated: October 16, 2007
Last verified: October 2007
Osteoporotic fractures of the hip are a major cause of admission to long-term care facilities. Such fractures put patients at high risk for further fractures, pain and disability. Current data show that many patients in long-term care facilities do not receive FDA medications for their osteoporosis. This trial will test whether a multi-model intervention (which provides feedback about provider use of osteoporosis medications, information about osteoporosis, and currently approved osteoporosis medications)directed at physicians, other health care providers, and nurses will improve the number of prescriptions written for FDA approved medications for osteoporosis treatment.

Condition Intervention Phase
Hip Fractures Osteoporosis Behavioral: Long-term care facilities in the intervention arm will receive education and feedback audit on performance Phase 2 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single
Primary Purpose: Prevention
Official Title: Secondary Prevention of Osteoporotic Fractures in Residents of Long-Term Care Facilities Written for FDA Approved Medications for Osteoporosis Treatment.

Resource links provided by NLM:

Further study details as provided by Duke University:

Primary Outcome Measures:
  • Number of new prescriptions for FDA-Approved osteoporosis medications.

Secondary Outcome Measures:
  • Secondary Outcome Measures: Changes in number of bone mineral density test ordered, change in the number of hip protectors issued, change in the number of prescriptions for calcium and vitamin D, changes in the rate of new osteoporotic fractures.

Estimated Enrollment: 64
Study Start Date: January 2005
Study Completion Date: March 2007

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Any North Carolina long-term care facility with ten residents who had had a hip fracture or osteoporosis diagnosis

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00280943

United States, North Carolina
Duke University Medical Center
Durham, North Carolina, United States, 27710
Sponsors and Collaborators
Duke University
Principal Investigator: Kenneth W Lyles, M.D. Duke University
Principal Investigator: Cathleen S. Colon-Emeric, MD, MHSc Duke University
  More Information

Publications: Identifier: NCT00280943     History of Changes
Other Study ID Numbers: 4686-05-7R2ER
Study First Received: January 20, 2006
Last Updated: October 16, 2007

Keywords provided by Duke University:
All NC LTC facilities having ten residents with a hip fracture or osteoporosis on the MDS will be invited to participate in the trial

Additional relevant MeSH terms:
Fractures, Bone
Hip Fractures
Osteoporotic Fractures
Wounds and Injuries
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Femoral Fractures
Hip Injuries
Leg Injuries processed this record on August 23, 2017